Explore evidence

796 per_1000En 2023, l'incidence du paludisme pendant la grossesse était de 796 pour 1000 femmes au Burkina Faso.

Burkina Fasopaludismeobserved 2023HAL · Unilimdocument of 302 observations

1.02 %In Sector 8, the morbidity rate for severe malaria among people over 5 years of age was 1.02% in 2022.

Burkina Fasopaludismeobserved 2022HAL · Unilimdocument of 110 observations

Isolates carrying both the Pfcrt K76 and Pfmdr-1 N86 alleles (wild/wild (WW)) and the single mutant Pfmdr-1 Y86 (WM) had the lowest IC50 geometric mean values in Plasmodium falciparum from patients with uncomplicated malaria in Burkina Faso.

Burkina Fasopaludismepublished 2003Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument of 4 observations

15.9 %RDT was significantly overall less sensitive than the QBC, with a false-negative rate of 15.9% by antigen HRP2 detection.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

10.2 %The risk of recurrent symptomatic malaria was 10.2% in the group given artemether-lumefantrine.

Burkina Fasopaludismepublished 2007Lancet (London, England)europe_pmcdocument of 5 observations

92.2 %In 2015, Burkina Faso reported a monthly seasonal malaria chemoprevention coverage rate of 92.2%.

Burkina Fasopaludismeobserved 2015HAL · Unilimdocument of 110 observations

45.1 %Vaccine efficacy of RTS,S/AS01 against severe malaria was 45.1% in the intention-to-treat population.

Burkina Fasopaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 7 observationsDOI 10.1056/nejmoa1102287

38.6 %Of the 57 patients who were febrile on examination, 22 had malaria, representing 38.6%.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

3.26 odds_ratioHeterozygote males were more competitive than homozygote susceptible males, with an odds ratio of 3.26 and P = 0.006.

Burkina Fasopaludismepublished 2015Heredityeurope_pmcdocument of 6 observations

22.6 %Of the 306 patients, 69 were diagnosed with malaria, representing 22.6%.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

0.4 proportionThe allele frequency of the L1014S kdr mutation conferring resistance to pyrethroids was 0.4.

Burkina Fasopaludismepublished 2017PloS oneeurope_pmcdocument of 7 observations

7 foldPatients with acute malaria or recovering from malaria had a 7-fold higher risk of presenting polymicrobial bloodstream infections compared to patients with no recent malaria diagnosis.

Burkina Fasopaludisme · polymicrobial bloodstream infectionspublished 2016PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations

23.4 %Of the 73,101 female Anopheles mosquitoes collected, 23.4% (17,083) were captured using CDC_LT.

Burkina Fasopaludismeobserved July 28, 2019 to February 27, 2022HAL · Unilimdocument of 87 observations

84.9 %At day 28, the PCR-corrected adequate clinical and parasitological response (ACPR) was 84.9% in the intention-to-treat population receiving the crushed-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublished 2018Antimicrobial agents and chemotherapyeurope_pmcdocument of 10 observations

2.58 odds_ratioHeterozygote RDL(R)/RDL(S) males were more likely to mate than homozygote-resistant males, with an odds ratio of 2.58 and P = 0.007.

Burkina Fasopaludismepublished 2015Heredityeurope_pmcdocument of 6 observations

44.4 %Of 3170 participants, 44.4% in the passive surveillance group reported at least one adverse event after use of artemisinin-based combination therapies.

Burkina Fasopaludismeobserved 2010–2012published 2020Drug design, development and therapyeurope_pmcdocument of 5 observations

3.62 %Mixed-species pairs captured in copula made up 3.62% of mating pairs involving An. coluzzii individuals.

Burkina Fasopaludismepublished 2015Parasites & vectorseurope_pmcdocument of 4 observationsDOI 10.1186/s13071-015-1190-x

27 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of approximately 27% in infants aged 6–12 weeks.

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

11 %The attributable fraction of fever to malaria was 11% in the dry season in Burkina Faso.

Burkina Fasopaludismeobserved dry seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192

25.3 titerAt day 180, the PfCSP-specific geometric mean titer (GMT) was 25.3 in the ProC6C-AlOH/Matrix-M group.

Burkina Fasopaludismeobserved D180HAL · Unilimdocument of 39 observations

1,280 casesIn 2023, simple malaria among children under 5 years in the Koudougou health district accounted for 1280 cases and represented 50.01% of malaria cases.

Burkina Fasopaludismeobserved 2023HAL · Unilimdocument of 110 observations

87.7 %In Sector 6, the simple malaria morbidity rate among people over 5 years of age was 87.70% in 2023.

Burkina Fasopaludismeobserved 2023HAL · Unilimdocument of 110 observations

86.9 %At day 28, the PCR-corrected adequate clinical and parasitological response (ACPR) was 86.9% in the intention-to-treat population receiving the dispersible-tablet formulation of dihydroartemisinin/piperaquine phosphate.

Burkina Fasopaludismepublished 2018Antimicrobial agents and chemotherapyeurope_pmcdocument of 10 observations

3.7 %In Orodara, the sporozoite infection rate (SIR) was 3.7% in year 3.

Burkina Fasopaludismeobserved year 3HAL · Unilimdocument of 87 observations

3.9 %Plasmodium ovale was identified in 3.9% of all infections.

Burkina Fasopaludismepublished 2008Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/1475-2875-7-174